China’s Biotech Revolution: How Innovative Is China in Global Pharmaceutical R&D and Novel Drug Development?
In the sprawling landscape of global health innovation, a seismic shift is underway, and its epicenter is increasingly found in China. For decades, the nation was primarily seen as the world’s factory
How China’s Pharmaceutical Industry is Pivoting from Generics to Biotech Innovation in 2024
The narrative of China’s pharmaceutical sector has fundamentally changed. For decades, the industry was synonymous with high-volume generic drug manufacturing, serving as the world’s pharmacy for cost
China’s NMPA Approves Vcare PharmaTech’s Next-Generation TRK Inhibitor Eratrectinib, Marking a Milestone in Domestic …
In a significant development for China's rapidly evolving biopharmaceutical sector, the National Medical Products Administration (NMPA) has granted marketing approval to Jiangsu Vcare PharmaTech's inn
Mabwell’s 9MW5211 Secures NMPA IND Clearance: A World’s-First Bispecific Antibody Poised to Disrupt the Inflammatory …
In a significant move that underscores China's rising prowess in biopharmaceutical innovation, Shanghai-based Mabwell Therapeutics has announced a major regulatory milestone. The company's independent
